K-18 is released during hepatocyte apoptosis and has been proposed as a marker of cell death in the liver 31
Cholesterol profiles improve significantly with GLP-1 treatment
Mukherjee, A., Hum, A., Gustafson, T
Peptide Products Ltd Company No
When to seek medical advice : Patients should contact their GP or diabetes specialist nurse if they experience: Severe, persistent vomiting preventing adequate fluid intake (risk of dehydration and acute kidney injury) Severe abdominal pain, particularly if radiating to the back (potential pancreatitisrare but serious) Right upper abdominal pain, fever, or yellowing of skin/eyes (potential gallbladder disease) Sudden vision changes (particularly with semaglutide, which may worsen diabetic retinopathy, especially with rapid HbA1c reduction) [40] [41] Signs of hypoglycaemia when used with insulin or sulphonylureas Allergic reactions (rash, difficulty breathing, facial swelling)call 999 or go to A&E for severe allergic reactions Patients should report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
Arctiko biomedical refrigerators and freezers are designed to secure GLP-1 at every stage of storage and distribution, ensuring reliability, compliance, and uninterrupted business operations
